Armistice Capital, LLC Aytu Biopharma, Inc Transaction History

Armistice Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.08 $1.09 Million - $2.57 Million	-2,379,936 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.08 - $1.55 $2.57 Million - $3.69 Million	2,379,936 New	2,379,936 $2.57 Million
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $3.73 Million - $6.87 Million	-1,342,378 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $56,344 - $89,354	9,044 Added 0.68%	1,342,378 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$5.98 - $13.5 $7.97 Million - $18 Million	1,333,334 New	1,333,334 $7.97 Million

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.